Novartis Submits Bexsero to FDA for Marketing Approval – Analyst Blog
Novartis ( NVS ) announced the submission of its Biologic License Application (BLA) for meningitis B vaccine candidate Bexsero to …read more
Novartis ( NVS ) announced the submission of its Biologic License Application (BLA) for meningitis B vaccine candidate Bexsero to …read more
Updates related to pipeline and label expansion efforts are eagerly awaited by investors in the biotech pharma space as these …read more
Solar module manufacturer Trina Solar Limited ( TSL ) will supply 23 MW of photovoltaic (“PV”) modules to Linuo Solar …read more
Ahead of the rumored release of its 3D smartphone on Jun 18 in Seattle, giant online retailer Amazon.com Inc. ( …read more
On Jun 13, 2014, we issued an updated research report on Robert Half International Inc ( RHI ). This global …read more
by Thomas Young In a couple of weeks, Nike, Inc. ( NKE ) will release earnings (June 26). Regardless of …read more
NRG Energy, Inc. ( NRG ) announced that it has launched the NRG Community 1 Solar Generating Facility in California. …read more
Gilead Sciences ( GILD ) announced encouraging top line results from a phase III study (GS US 337 0113 n=341) …read more
There’s certain stocks analysts don’t want you to buy and today we’re bringing you an article to explain why. Here’s a quote, “Seeing a sell… Read More »Why Analysts Don’t Want You To Buy These Stocks
By Jeff Miller Into the economic news vacuum, summer doldrums, and sports stories, there was finally some real news the …read more